Takeda Pharmaceutical Statistics
NYSE: TAKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
18.73+0.21 (+1.13%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 18.67 -0.29%
Takeda Pharmaceutical by the numbers
Takeda Pharmaceutical has a market capitalization of $59.83 billion based on 3.19B shares outstanding. With trailing EPS of $-0.34, Takeda Pharmaceutical is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 3.6% above its 50-day average and 8.7% above its 200-day average.
Average daily trading volume is 3.04M shares, or about $56.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TAK valuation vs. peer median
| Metric | TAK | Peer median | Difference |
|---|---|---|---|
| Market cap | $59.83B | $36.61B | +63% |
| Forward P/E | 35.3 | 12.1 | +192% |
| Dividend yield | 1067.81% | 1.53% | +69673% |
| Avg. volume | 3.04M | 3.39M | -10% |
Peer median across 8 companies: TEVA, REGN, ONC, RPRX, ALNY, ZTS, GSK, ROIV.
Valuation
- Market cap
- $59.83B
- Forward P/E
- 35.34
- EPS (TTM)
- $-0.34
- Shares outstanding
- 3.19B
Price and trading
- Previous close
- 18.52
- Open
- 18.37
- Day range
- 18.40 – 18.76
- 52-week range
- 12.99 – 19.10
- 52-week change
- +29.42%
- Beta
- —
- Volume
- 2.04M
- Average volume
- 3.04M
Dividends and events
- Annual dividend
- $200.00
- Dividend yield
- 1067.81%
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 59.83B
- Forward Pe
- 35.34
- Eps
- -0.34
- Dividend Yield
- 3.33%
- Dividend Rate
- 200.00
- Week52 High
- 19.10
- Week52 Low
- 12.99
- Avg Volume
- 3.04M
- Shares Outstanding
- 3.19B
- Ma50
- 18.08
- Ma200
- 17.24
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -1.94%
- Pct From52w Low
- 44.19%